GTMRx National Physician Advisory Group
The physician is the clinical gateway to a patient’s medication management process, initiating therapeutic decisions in order to achieve specific clinical goals. Today’s care environment is complex—between multiple electronic interfaces (EHR’s and others) and quality and value-based mandates. However, physicians are not alone in this management challenge. The GTMRx Institute is advancing team-based, patient-centered care models that recognize appropriately skilled clinical pharmacists as medication experts who work in collaborative practice with physicians and other providers optimizing medication use through comprehensive medication management (CMM) in practice.
The goal of the Physician Advisory Group is to provide leadership guidance and recommendations that will enable broad practice adoption of a systematic approach to medication use (CMM) throughout the continuum of care. This will be achieved by physician advisor evaluation, review and ongoing recommendations.
The Physician Advisory Group will be called upon to offer feedback and guidance to advance access to CMM services (payment, practice and policy)—through the lens of a physician. Overall, success will be defined as raising awareness, adoption and advocacy among physician colleagues of the value of inter-professional team-based care to optimize medication through CMM in practice.
Co-Chair: Paul Grundy, MD, MPH, FACOEM, FACPM, President, GTMRx Institute; Chief Transformation Officer, Innovaccer
Co-Chair: Ira Klein, MD, MBA, FACP, Vice President, Provider Relations, Tempus; Board Member, GTMRx Institute
Advisor: Julie England, MD, Medical Director of Medical Affairs, OneOme; Co-Founder, Epigenetic Endeavors
Advisor: Allan Goroll, MD, Professor of Medicine, Harvard Medical School, Massachusetts General Hospital
Advisor: Mitchell Kaminski, MD, MBA, Program Director, Population Health, Jefferson College of Population Health
Advisor: Chet Robson, DO, MHCDS, FAAFP, (formerly) Chief Clinical Officer, Office of Clinical Integrity, Walgreens
Advisor: Julia Skapik, MD, MPH, Medical Director, National Association of Community Health Centers (NACHC)
Advisor: William Stanford, MD, Ph.D., FACP, Chief Medical and Scientific Officer, Beverly Hills Institute for Precision Medicine
Advisor: Peter Teichman, MD, MPA, Family Medicine Clinician & Primary Care IT Lead, Asante Physician Partners
- Review current and proposed CMM best practices and explore methods proven to enhance physician satisfaction, leadership, engagement and support.
- Examine key elements and strong practices around collaborative practice agreements (CPAs) that might serve as models to strive for uniformity in the primary care and specialty setting.
- Review and evaluate existing value-based business agreements with the intent of spreading profitable and sustainable practices to support CMM expansion.
- Review current literature evaluating proven methods for CMM integration and offer guidance for dissemination and repurposing to impact physician support and engagement.
- Focusing on the quadruple aim components: quality, lower cost of care, patient satisfaction and joy in practice (physician/care team satisfaction).
- Evaluate GTMRx workgroup guidance documents focused on research and policy to advance CMM in practice and guide physician interest.
- Offer guidance to advance the business case to demonstrate the value of CMM services to physicians (along with patients and other providers) in order improve demand and engagement.
- Define key barriers and solutions to improving access to health IT that liberate clinical data and allow for efficient CMM practice delivery within the interprofessional care team (physician with the patient, clinical pharmacist and others on the CMM care team).
- Define key barriers and solutions to improve access to companion and complimentary diagnostics (e.g. pharmacogenomics testing as part of the CMM process of care) within the interprofessional care team (physician with the patient, clinical pharmacist and others on the CMM care team).